Commerzbank Aktiengesellschaft FI Has $2.27 Million Stock Position in The Cigna Group (NYSE:CI)

Commerzbank Aktiengesellschaft FI boosted its holdings in shares of The Cigna Group (NYSE:CI) by 231.5% in the fourth quarter, HoldingsChannel reports. The fund owned 8,245 shares of the health services provider’s stock after buying an additional 5,758 shares during the quarter. Commerzbank Aktiengesellschaft FI’s holdings in The Cigna Group were worth $2,269,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Collier Financial acquired a new stake in shares of The Cigna Group during the fourth quarter worth approximately $32,000. ORG Wealth Partners LLC purchased a new stake in The Cigna Group in the 4th quarter worth approximately $34,000. Prospera Private Wealth LLC purchased a new stake in The Cigna Group in the 3rd quarter worth approximately $37,000. Compagnie Lombard Odier SCmA acquired a new stake in shares of The Cigna Group during the 4th quarter valued at $37,000. Finally, Harbor Capital Advisors Inc. purchased a new position in shares of The Cigna Group during the 3rd quarter valued at $45,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

The Cigna Group Trading Up 0.9 %

The Cigna Group stock opened at $311.50 on Tuesday. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The firm has a market capitalization of $86.64 billion, a PE ratio of 25.45, a PEG ratio of 0.98 and a beta of 0.54. The business’s 50-day simple moving average is $290.14 and its 200-day simple moving average is $318.34.

The Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same period in the prior year, the company earned $6.79 earnings per share. Equities research analysts forecast that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a yield of 1.94%. The ex-dividend date of this dividend is Wednesday, March 5th. The Cigna Group’s dividend payout ratio is presently 49.35%.

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Barclays cut their price objective on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Oppenheimer reduced their price target on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a report on Friday, January 31st. Deutsche Bank Aktiengesellschaft dropped their price objective on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Stephens reduced their target price on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Finally, Raymond James reissued a “strong-buy” rating and issued a $360.00 target price (down from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, The Cigna Group currently has an average rating of “Buy” and a consensus target price of $372.31.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.